InvestorsHub Logo
Followers 82
Posts 9659
Boards Moderated 1
Alias Born 01/26/2014

Re: Brooklyn75 post# 199

Wednesday, 05/30/2018 9:27:42 AM

Wednesday, May 30, 2018 9:27:42 AM

Post# of 231
BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica

https://globenewswire.com/news-release/2018/05/30/1513731/0/en/BELGRAVIA-CAPITAL-completes-acquisition-of-interest-in-R-D-Pharma-Corp-a-Canadian-corporation-building-a-vertically-integrated-medical-cannabis-business-in-Jamaica.html

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce that it has acquired 10.03% of the outstanding common shares of R&D Pharma Corp. (“RDP”). RDP is a Canadian corporation developing a vertically integrated medicinal cannabis business in Jamaica. Belgravia has acquired four million (4 million) common shares of RDP at a price of twenty-five (25) cents per share. Belgravia has the right to appoint an independent director to the Board of RDP. Mr. Kevin Strong, the Chief Financial Officer (“CFO”) of Belgravia, has been appointed CFO of RDP. The funding of the acquisition was by way of Canadian $500,000 (five-hundred thousand dollars) and 5,000,000 (five million) common shares of Belgravia.